Top 5 Takeaways High Provider Accessibility: By 11 weeks after the pediatric COVID-19 vaccination program launch, 92% of children aged 5–11 years lived within 5 miles of a vaccine provider.
Blog
Top 5 Takeaways Emerging Substance: Xylazine, a veterinary tranquilizer, is increasingly found in drug overdose deaths in Connecticut. Combination with Fentanyl: Nearly all xylazine-positive deaths also involved fentanyl, highlighting a
Top 5 Takeaways High Adverse Event Rate: 91.4% of patients reported experiencing at least one adverse event during treatment with nifurtimox. Demographic Concentration: Most patients were adults aged ≥18 years
Top 5 Takeaways Xylazine Detection: Xylazine was detected in 1.8% of overdose deaths reported to the State Unintentional Drug Overdose Reporting System (SUDORS) in 2019. Xylazine Involvement: Xylazine was listed
Top 5 Takeaways High Specificity: The study found that the specificity of DENV and SARS-CoV-2 enzyme-linked immunosorbent assays (ELISAs) was ≥98%, indicating minimal cross-reactivity. Minimal Cross-Reactivity: Results showed minimal levels
Top 5 Takeaways Low Vaccine Effectiveness: The 2021–22 seasonal influenza vaccine showed only 16% effectiveness against medically attended outpatient ARI caused by influenza A(H3N2) viruses. Predominance of A(H3N2): Most influenza
Top 5 Takeaways High Vaccine Effectiveness: COVID-19 mRNA vaccines were 86.8% effective in preventing COVID-19–associated hospitalization among U.S. veterans. Effectiveness Across Variants: The effectiveness remained high during both pre-Delta (84.1%)
Top 5 Takeaways High Overall Vaccine Effectiveness: COVID-19 vaccines showed high effectiveness against hospitalization (86%) and emergency department/urgent care (ED/UC) encounters (82%) during the Delta variant predominance. Age-Related Differences: Vaccine
Top 5 Takeaways Increased Hospitalization Rates: During the Omicron variant predominance, infants and children aged 0–4 years were hospitalized at approximately five times the rate compared to the Delta variant
Top 5 Takeaways Vaccine Effectiveness: The study found a potential decline in vaccine protection against confirmed SARS-CoV-2 infection but continued strong protection against COVID-19–associated hospitalization and death. Impact of Delta